Difference between revisions of "Comment Resolutions"
Jump to navigation
Jump to search
m |
m |
||
Line 26: | Line 26: | ||
| 2019.06.03 | | 2019.06.03 | ||
| [[Media:QIBA CTA Comments all resolved.xlsx| Public Comment Resolutions 2020-03-12]] | | [[Media:QIBA CTA Comments all resolved.xlsx| Public Comment Resolutions 2020-03-12]] | ||
+ | |- | ||
+ | | [[Media:QIBA CTA Profile as of 2023-Feb-16.pdf| CT Atherosclerosis 2023-02-16]] | ||
+ | | Clinically Feasible | ||
+ | | 2023.02.16 | ||
+ | | [[Media:QIBA CTA Comments (02.16.2023).xlsx| Clinically Feasible Comment Resolutions 2023-02-16]] | ||
|- | |- | ||
| [[Media:QIBA CT Lung Density Profile 090420-clean.pdf| CT Lung Density 2020-09-04]] | | [[Media:QIBA CT Lung Density Profile 090420-clean.pdf| CT Lung Density 2020-09-04]] |
Revision as of 19:32, 16 February 2023
Comments received during Public Comment, Clinically Feasible (formerly Technical) Confirmation, or during a Profile ballot, are reviewed by the originating Biomarker Committee.
Per the QIBA Process, committees record how each collected comment was resolved and those resolutions are posted here.